GLATOPA Trademark

Trademark Overview

On Monday, March 21, 2011, a trademark application was filed for GLATOPA with the United States Patent and Trademark Office. The USPTO has given the GLATOPA trademark a serial number of 85271930. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 3, 2014. This trademark is owned by Novartis AG. The GLATOPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in human medicine for the treatment of multiple sclerosis
glatopa

General Information

Serial Number85271930
Word MarkGLATOPA
Filing DateMonday, March 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 3, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in human medicine for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 24, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, November 3, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 3, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 19, 2014EXTENSION 5 GRANTED
Monday, March 17, 2014EXTENSION 5 FILED
Monday, March 17, 2014TEAS EXTENSION RECEIVED
Wednesday, September 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2013EXTENSION 4 GRANTED
Friday, September 13, 2013EXTENSION 4 FILED
Friday, September 13, 2013TEAS EXTENSION RECEIVED
Wednesday, March 27, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2013EXTENSION 3 GRANTED
Monday, March 11, 2013EXTENSION 3 FILED
Tuesday, March 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 11, 2013TEAS EXTENSION RECEIVED
Thursday, September 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2012EXTENSION 2 GRANTED
Monday, September 24, 2012EXTENSION 2 FILED
Tuesday, September 25, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 24, 2012TEAS EXTENSION RECEIVED
Thursday, March 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 13, 2012EXTENSION 1 GRANTED
Tuesday, March 13, 2012EXTENSION 1 FILED
Tuesday, March 13, 2012TEAS EXTENSION RECEIVED
Tuesday, September 27, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2011ASSIGNED TO EXAMINER
Thursday, March 24, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

glatopa multiple sclerosis treatment medicine preparations human pharmaceutical